These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 28988621)
61. Induction of IgG rheumatoid factor (RF) production by antibody-antibody (RF-like) immune complexes: the role of T cells, complement and Fc gamma receptors. Nordström E; Möller E; Abedi-Valugerdi M J Autoimmun; 1998 Apr; 11(2):131-40. PubMed ID: 9650092 [TBL] [Abstract][Full Text] [Related]
62. The high-affinity receptor for IgG, FcγRI, of humans and non-human primates. Chenoweth AM; Trist HM; Tan PS; Wines BD; Hogarth PM Immunol Rev; 2015 Nov; 268(1):175-91. PubMed ID: 26497520 [TBL] [Abstract][Full Text] [Related]
63. Analysis of monoclonal antibody oxidation by simple mixed mode chromatography. Pavon JA; Li X; Chico S; Kishnani U; Soundararajan S; Cheung J; Li H; Richardson D; Shameem M; Yang X J Chromatogr A; 2016 Jan; 1431():154-165. PubMed ID: 26774436 [TBL] [Abstract][Full Text] [Related]
64. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730 [TBL] [Abstract][Full Text] [Related]
65. Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody. Pace D; Lewis N; Wu T; Gillespie R; Leiske D; Velayudhan J; Rohrbach A; Connell-Crowley L Biotechnol Prog; 2016 Sep; 32(5):1181-1192. PubMed ID: 27160519 [TBL] [Abstract][Full Text] [Related]
66. The rs150311303 polymorphism in FcγRIIa enhances IgG binding capacity. Omar AH; Shibata H; Yasunami M; Yamazaki A; Ofori MF; Akanmori BD; Shuaibu MN; Kikuchi M; Hirayama K Scand J Immunol; 2012 Aug; 76(2):167-74. PubMed ID: 22540264 [TBL] [Abstract][Full Text] [Related]
67. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection. Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769 [TBL] [Abstract][Full Text] [Related]
68. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes. Voice JK; Lachmann PJ Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604 [TBL] [Abstract][Full Text] [Related]
69. Single Nucleotide Polymorphisms of the High Affinity IgG Receptor FcγRI Reduce Immune Complex Binding and Downstream Effector Functions. Brandsma AM; Ten Broeke T; van Dueren den Hollander E; Caniels TG; Kardol-Hoefnagel T; Kuball J; Leusen JHW J Immunol; 2017 Oct; 199(7):2432-2439. PubMed ID: 28814603 [TBL] [Abstract][Full Text] [Related]
70. Implication for how the single nucleotide polymorphism (SNP) of Fc receptor, Fc gamma RIIIa alters the interaction with anti-CD20 monoclonal antibody. Oshima Y; Fujimura A Blood; 2002 Jun; 99(12):4649; author reply 4650. PubMed ID: 12066789 [No Abstract] [Full Text] [Related]
71. Clinical implications of the polymorphic interaction of murine IgG2b and IgG1 with human Fc receptors. Tax WJ; Holtrop S; Koene RA Transpl Immunol; 1993; 1(4):250-2. PubMed ID: 8081781 [No Abstract] [Full Text] [Related]
72. Effect of photo-degradation on the structure, stability, aggregation, and function of an IgG1 monoclonal antibody. Shah DD; Zhang J; Maity H; Mallela KMG Int J Pharm; 2018 Aug; 547(1-2):438-449. PubMed ID: 29883793 [TBL] [Abstract][Full Text] [Related]
73. Mass spectrometry analysis of photo-induced methionine oxidation of a recombinant human monoclonal antibody. Liu H; Gaza-Bulseco G; Zhou L J Am Soc Mass Spectrom; 2009 Mar; 20(3):525-8. PubMed ID: 19103498 [TBL] [Abstract][Full Text] [Related]
74. The influence of periodate oxidation on monoclonal antibody avidity and immunoreactivity. Abraham R; Moller D; Gabel D; Senter P; Hellström I; Hellström KE J Immunol Methods; 1991 Nov; 144(1):77-86. PubMed ID: 1660058 [TBL] [Abstract][Full Text] [Related]
75. Biolayer Interferometry-based FcγRIIa binding assay for a therapeutic antibody with strong effector function. Bajardi-Taccioli A; Co C; Bond C; Masci A; Brantley T; Xu C; Bergelson S; Feschenko M Anal Biochem; 2020 Dec; 611():113842. PubMed ID: 32755599 [TBL] [Abstract][Full Text] [Related]
76. Loop Grafting between Similar Local Environments for Fc-Silent Antibodies. Lešnik S; Hodošček M; Podobnik B; Konc J J Chem Inf Model; 2020 Nov; 60(11):5475-5486. PubMed ID: 32379970 [TBL] [Abstract][Full Text] [Related]
77. Detection and Identification of the Vibrational Markers for the Quantification of Methionine Oxidation in Therapeutic Proteins. Balakrishnan G; Barnett GV; Kar SR; Das TK Anal Chem; 2018 Jun; 90(11):6959-6966. PubMed ID: 29741878 [TBL] [Abstract][Full Text] [Related]
78. Identification of potential sites for tryptophan oxidation in recombinant antibodies using tert-butylhydroperoxide and quantitative LC-MS. Hensel M; Steurer R; Fichtl J; Elger C; Wedekind F; Petzold A; Schlothauer T; Molhoj M; Reusch D; Bulau P PLoS One; 2011 Mar; 6(3):e17708. PubMed ID: 21390239 [TBL] [Abstract][Full Text] [Related]
79. Effect of UVC Irradiation on the Oxidation of Histidine in Monoclonal Antibodies. Miyahara Y; Shintani K; Hayashihara-Kakuhou K; Zukawa T; Morita Y; Nakazawa T; Yoshida T; Ohkubo T; Uchiyama S Sci Rep; 2020 Apr; 10(1):6333. PubMed ID: 32286391 [TBL] [Abstract][Full Text] [Related]
80. Antibody-mediated targeting of viral vectors to the Fc receptor expressed on acute myeloid leukemia cells. Würdinger T; Verheije MH; van der Aa LM; Bosch BJ; de Haan CA; van Beusechem VW; Gerritsen WR; Rottier PJ Leukemia; 2006 Dec; 20(12):2182-4. PubMed ID: 17039233 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]